BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Deals

  Novartis AG Needs Alcon Laboratories, Inc. Directors’ OK for Buyout Says Advisor

  June 28, 2010

   · 

  6 min read
• Drug Development

  Halozyme Therapeutics, Inc. Insulin Drug Meets Mid-Stage Study Goal

  June 28, 2010

   · 

  7 min read
• Genetown

  Picis, Inc. Release: Bayonne Medical Center Modernizes Emergency Department with Picis EDIS

  June 28, 2010

   · 

  1 min read
• Drug Development

  Sanofi-Aventis (France): Improved Outcomes for Patients Treated with Lantus(R) and Apidra(R) Regimen Compared with Sliding Scale Insulin

  June 28, 2010

   · 

  6 min read
• Drug Development

  Orexigen Therapeutics, Inc. Presents New Data Showing Contrave(R) Significantly Lowers Weight, Improves Blood Glucose Control in Obese Patients With Type 2 Diabetes

  June 28, 2010

   · 

  7 min read
• Drug Development

  Biodel Inc.: Final Results of Phase 3 Study of VIAject(R) vs. Regular Human Insulin in Patients with Type 2 Diabetes Presented at American Diabetes Association Annual Meeting

  June 28, 2010

   · 

  6 min read
• FDA

  Masimo Corporation Receives FDA Clearance for Pronto-7 Making the Revolutionary Palm-sized Device for Noninvasive Hemoglobin Spot-Check Testing Available to U.S. Healthcare Providers

  June 28, 2010

   · 

  7 min read
• Drug Development

  Amylin Pharmaceuticals, Inc. Study Finds BYETTA(R) Use Was Not Associated With Increased Rate of Acute Pancreatitis Compared to Other Antidiabetic Drugs: Final Results Presented at American Diabetes Association 2010

  June 28, 2010

   · 

  9 min read
• Policy

  BARRX Medical, Inc.: National Institute for Clinical Excellence (NICE) Approves the Use of Radiofrequency Ablation for Treatment of Barrett’s Esophagus

  June 28, 2010

   · 

  3 min read
• Business

  NOXXON Pharma AG Announces CEO Dr. Frank Morich will Leave Company

  June 28, 2010

   · 

  2 min read